首页|期刊导航|肿瘤学与转化医学（英文）|In vivo study of the effect of anlotinib on the stemness of the lenvatinib-resistant hepatocellular carcinoma cells and the underlying mechanisms

In vivo study of the effect of anlotinib on the stemness of the lenvatinib-resistant hepatocellular carcinoma cells and the underlying mechanisms

Jing Zhan Shu Huang Bai Wei Zao-Zao Huang Sheng-Li Yang

肿瘤学与转化医学（英文）2024，Vol.10Issue(1)：4-12,9.

肿瘤学与转化医学（英文）2024，Vol.10Issue(1)：4-12,9.DOI:10.1097/ot9.0000000000000030

In vivo study of the effect of anlotinib on the stemness of the lenvatinib-resistant hepatocellular carcinoma cells and the underlying mechanisms

Jing Zhan ¹Shu Huang ²Bai Wei ³Zao-Zao Huang ⁴Sheng-Li Yang⁵

作者信息

1. Division of Oncology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China
2. Department of Hepatology of Integrated Traditional Chinese and Western Medicine, The Third People's Hospital of Hubei Province Affiliated to Jianghan University, Wuhan, China
3. Division of Oncology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4. Yangchunhu Community Hospital, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China||Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, China||Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
折叠

摘要

关键词

Anlotinib/HCC/Lenvatinib-resistant/Notch signaling pathway

Key words

Anlotinib/HCC/Lenvatinib-resistant/Notch signaling pathway

引用本文复制引用

Jing Zhan,Shu Huang,Bai Wei,Zao-Zao Huang,Sheng-Li Yang..In vivo study of the effect of anlotinib on the stemness of the lenvatinib-resistant hepatocellular carcinoma cells and the underlying mechanisms[J].肿瘤学与转化医学（英文）,2024,10(1):4-12,9.

基金项目

This study was supported by the Natural Science Foundation of the Hubei Province (no.2023 AFB894)and Open for the Key Laboratory of Biological Targeted Therapy in 2021(no.2021swbx019). （no.2023 AFB894）

肿瘤学与转化医学（英文）

OACSTPCD

ISSN：2095-9621

访问量0

下载量0

段落导航